Equity · Healthcare
ABBV
NYSEAbbVie (ABBV)
The line runs 245.39 USD on 3 August through 294.82 USD on 30 October, on a scale from 240 to 300. Days the market did not trade hold the previous close, flat.
- Market cap
- 521.0B USD
- P/E (TTM)
- 83.3
- Revenue, year to Dec 2025
- 61.2B USD
- EPS, diluted, year to Dec 2025
- 2.36 USD
- 52-week range
- 195 USD – 294.82 USD
- Avg volume
- 207.8K
- Mentions, 30 days
- 19
- Net sentiment
- +0.11
as of Oct 30, 2026
Have AbbVie (ABBV) insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, AbbVie insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 30 Sep 2025, show no open-market purchase.
Form 4, 90 days to 1 Nov 2026, newest reported trade 14 Aug 2026
Buys 0Sells 1Net sold $8.18MOther filings 1
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 14 Aug 2026 | Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICER | Sell | 32,710 | 8.2M USD |
1 other filing in the window: a grant, exercise, tax withholding or transfer, not a trade
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 14 Aug 2026 | Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICER | Option exercise | 32,710 | 2.6M USD |
Which funds hold AbbVie (ABBV)?
13 of the 45 institutional funds we track reported a AbbVie position for the quarter ended 30 Jun 2026 — a combined 6.1B USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Held (±25%) | 9,497,970 | 2.4B USD | +4.5% |
| Citadel Advisors | Added | 3,169,783 | 797.6M USD | +546.5% |
| Marshall Wace | Added | 2,990,512 | 752.5M USD | +281,757.9% |
| D. E. Shaw & Co. | Added | 2,102,316 | 529.0M USD | +212.4% |
| AQR Capital Management | Added | 2,015,238 | 507.1M USD | +126.7% |
| Man Group | Held (±25%) | 1,704,016 | 428.8M USD | −4.0% |
| Millennium Management | Added | 1,516,475 | 381.6M USD | +124.4% |
| Balyasny Asset Management | Added | 622,946 | 156.8M USD | +1,673.3% |
| Point72 Asset Management | New position | 366,836 | 92.3M USD | |
| Two Sigma Investments | Held (±25%) | 198,249 | 49.9M USD | +11.1% |
Showing the 10 largest of 13 reported positions. The figures above count all of them.
Have members of Congress traded AbbVie (ABBV)?
The most recent congressional trade disclosed in AbbVie is a sale by Josh Gottheimer (house, NJ), dated 05 May 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 05 May 2026 | Josh Gottheimerhouse · Democrat–NJ | Sale | 1K USD–15K USD | 29 days |
| 08 Dec 2025 | Julia Letlowhouse · Republican–LA | Sale | 1K USD–15K USD | 36 days |
| 13 Nov 2025 | Julie Johnsonhouse · Democrat–TX | Sale | 1K USD–15K USD | 28 days |
| 31 Oct 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 21 days |
| 30 Oct 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 22 days |
| 30 Oct 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 22 days |
| 14 Aug 2025 | Julie Johnsonhouse · Democrat–TX | Sale | 1K USD–15K USD | 28 days |
| 22 Jul 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 22 days |
AbbVie (ABBV) US federal contracts
US federal agencies committed 386K USD in contracts to AbbVie (ABBV) in fiscal 2026, the year to 30 Sep 2026, against 587K USD the year before.
USAspending.gov
| Fiscal year | Committed |
|---|---|
| Fiscal 2026 (Oct 2025 to Sep 2026) | 386K USD |
| Fiscal 2025 (Oct 2024 to Sep 2025) | 587K USD |
| Fiscal 2024 (Oct 2023 to Sep 2024) | 727K USD |
| Fiscal 2023 (Oct 2022 to Sep 2023) | 258K USD |
Contracts of US$100,000 or more signed since April 2022; the amount is what the government has committed so far, which grows when options are exercised. Defense Department contracts are published about 90 days after signing, so the latest year is still filling in.
What has been filed or recorded for AbbVie (ABBV)?
The filings we hold for AbbVie, newest first: 12 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 355 shares | 100K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 28 shares | 8K USD notional · <0.001% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 5,644 shares | 1.5M USD notional · <0.001% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 16 shares | 4K USD notional · <0.001% of shares out |
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 58 shares | 15K USD notional · <0.001% of shares out |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 4,780 shares | 1.3M USD notional · <0.001% of shares out |
| 25 Sep 2026 | Fails to deliver | Shares failed to deliver | 99,862 shares | 26.5M USD notional · 0.006% of shares out |
| 24 Sep 2026 | Fails to deliver | Shares failed to deliver | 37,439 shares | 9.9M USD notional · 0.002% of shares out |
| 22 Sep 2026 | Fails to deliver | Shares failed to deliver | 2,137 shares | 565K USD notional · <0.001% of shares out |
| 18 Sep 2026 | Fails to deliver | Shares failed to deliver | 590 shares | 156K USD notional · <0.001% of shares out |
| 17 Sep 2026 | Fails to deliver | Shares failed to deliver | 93 shares | 24K USD notional · <0.001% of shares out |
| 16 Sep 2026 | Fails to deliver | Shares failed to deliver | 19 shares | 5K USD notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 2.03 USD | Revenue $16.99B |
| 30 Jun 2026 | Financials | Total assets | 135.1B USD | at period end |
| 30 Jun 2026 | Financials | Total equity | −5.9B USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.39 USD | Revenue $15.00B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 1.02 USD | Revenue $16.62B |
| 31 Dec 2025 | Financials | Revenue | 61.2B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 4.2B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 2.36 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.10 USD | Revenue $15.78B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.52 USD | Revenue $15.42B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.72 USD | Revenue $13.34B |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −0.02 USD | Revenue $15.10B |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS 0.88 USD | Revenue $14.46B |
What is Reddit saying about AbbVie (ABBV)?
Reddit mentioned ABBV 19 times in the 30 days to 31 October 2026, across 4 of the communities we track. All of them were scored for sentiment: 79% read bullish, 0% bearish and 21% neither. Reddit data updated 31 October 2026.
30-day window, Method
Mentions, 30 days 19Bullish 79%Bearish 0%Communities 4Against the market +25 points
How do Reddit mentions of AbbVie (ABBV) compare with its price?
Share ↗
Where AbbVie (ABBV) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 63% | 12 | +0.10 |
| r/stocks | 26% | 5 | +0.09 |
| r/etfs | 5% | 1 | +0.21 |
| r/investing | 5% | 1 | +0.22 |
Moves with AbbVie (ABBV)
Tickers whose daily Reddit volume rose and fell with AbbVie (ABBV)'s. Co-discussion, not price.
JEPQ +0.73ATOM +0.67PAAA +0.65GARP +0.65XOM +0.64IONQ +0.62
How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations), Method
AbbVie (ABBV): frequently asked questions
What did AbbVie shares close at?
AbbVie closed at 294.82 USD on 30 Oct 2026, up 0.96% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is AbbVie’s market cap?
AbbVie is worth 521.0B USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is AbbVie’s P/E ratio?
AbbVie has a price-to-earnings ratio of 83.3, as of 30 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is AbbVie’s revenue?
AbbVie reported revenue of 61.2B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have AbbVie insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, AbbVie insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 30 Sep 2025, show no open-market purchase. A further 1 filing was a grant, award, gift or exercise rather than an open-market trade. See Insiders
Which funds own AbbVie?
13 of the 45 funds we track reported a AbbVie position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Fisher Asset Management, Citadel Advisors and Marshall Wace. See Funds
Have members of Congress traded AbbVie?
Yes. 55 trades in AbbVie appear in the congressional disclosures we hold; the latest is a sale by Josh Gottheimer (House, NJ) dated 5 May 2026, filed 3 Jun 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did AbbVie last report earnings?
AbbVie last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of 2.03 USD; no next date is announced in SEC filings yet. See Filings
Does AbbVie have government contracts?
Yes. US federal agencies committed 386K USD in contracts to it in fiscal 2026, the year to 30 Sep 2026 (USAspending.gov). See Contracts
What is Reddit saying about AbbVie?
AbbVie was mentioned 4 times in the last 7 days across the finance subreddits we track, and 19 times over the trailing 30 days. Of the 19 mentions scored for sentiment, 79% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- USAspendingUSAspending.gov (U.S. Department of the Treasury), federal prime contract awards
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings